kaopubear | 靠谱熊

What are we talking about when talking about tumor biomarkers

Original link: https://kaopubear.top/blog/2025-05-03-how-to-learn-biomarker/ This article is a trial version of the content of the Xiongyan Xiongyu email newsletter membership plan . For the full content, please click on the newsletter homepage to subscribe and view it. written in front Hello, I am a bear who thinks about problems. This content is exclusive to readers who […]

What are we talking about when talking about tumor biomarkers Read More »

How Difficult is Precision Tumor Therapy? Look at the 7 Obstacles in Clinical Practice

Original link: https://kaopubear.top/blog/2022-03-14-clinical-practice-gaps/ In other words, besides “expensive”, what other factors affect the application of precision cancer treatment in clinical practice? A conversation that took place during Chinese New Year this year is as follows: : Young man, where do you get rich? : Uh, I didn’t get rich. : So what are you fussing

How Difficult is Precision Tumor Therapy? Look at the 7 Obstacles in Clinical Practice Read More »

Review of the Progress of Cancer Precision Therapy in 2022, OncoKB and FDA Approvals Are Enough

Original link: https://kaopubear.top/blog/2022-12-17-newsletter-pro-2022-precision-oncology/ This article is a trial version of the content of the Xiongyan Xiongyu email newsletter membership plan . For the full content, please click on the newsletter homepage to subscribe and view it. written in front Hello, I am a bear who thinks about problems. This content is exclusive to readers who

Review of the Progress of Cancer Precision Therapy in 2022, OncoKB and FDA Approvals Are Enough Read More »

Foundation Medicine’s 420,000-case sample library analyzed the KRAS pan-cancer mutation characteristics and came to these conclusions

Original link: https://kaopubear.top/blog/2022-12-16-fmi-kars-pancancer-landscape/ Both KRAS and HRAS, as well as NRAS, belong to the RAS family, and these genes, when mutated, can initiate or promote tumor growth. Although KRAS is a common mutated oncogene in many tumors, the protein encoded by the KRAS gene is like a smooth ball, and it is difficult to find

Foundation Medicine’s 420,000-case sample library analyzed the KRAS pan-cancer mutation characteristics and came to these conclusions Read More »

From a Nature paper in 2002 to a revenue of 100 million yuan in 2022

Original link: https://kaopubear.top/blog/2022-12-15-mammaprint-intro-from-nature-to-product/ The pleasure of reading literature usually lies outside the literature. Connect seemingly unrelated content through clues in the literature and off-site information. If you happen to answer the questions that have been lingering in your mind for a long time, it will be a rare “Paper Aha Moment”. What is the fun

From a Nature paper in 2002 to a revenue of 100 million yuan in 2022 Read More »

How do newcomers in the tumor NGS industry build their own knowledge system

Original link: https://kaopubear.top/blog/2022-12-10-cancerngs-newbie-guide/ This article is a selection of the content of the Xiongyan Xiongyu email newsletter membership plan . If you are also a newcomer in the industry, maybe there will be a little inspiration; if not, you might as well share it with the newcomers in the industry around you~ Regarding writing, I

How do newcomers in the tumor NGS industry build their own knowledge system Read More »

Xiongyan Xiongyu email newsletter is here, subscribe with 1600+ readers

Original link: https://kaopubear.top/blog/2022-12-04-kaopubear-newsletter-intro/ After a period of preparation and adjustment (actually a long time), the Xiongyan Xiongyu member newsletter will resume next week and continue to be updated. The following is the latest email content to share with you~ written in front Hello, I’m Thinking Bear, it’s a pleasure to meet you through this email

Xiongyan Xiongyu email newsletter is here, subscribe with 1600+ readers Read More »

Nature Genetics: Good news for patients with low TMB Tumor aneuploidy can predict the efficacy of pan-cancer immunotherapy

Original link: https://kaopubear.top/blog/2022-12-02-tumor-aneuploidy-predicts-ici-survival/ written in front The book continues from the previous chapter. In yesterday’s article, we started from the experience of publishing two large sub-journals of Nature in one day. We mentioned that Liam Flinn Spurr of the University of Chicago published an article in Nature Cancer as the first author on November 28.

Nature Genetics: Good news for patients with low TMB Tumor aneuploidy can predict the efficacy of pan-cancer immunotherapy Read More »

Also doing tumor NGS testing, how are the 9 companies listed on the US stock market?

Original link: https://kaopubear.top/blog/2022-09-01-tumor-ngs-2022q2-financial-results/ Disclaimer: The professional/industry-related information of all articles on this blog are all sourced from public information, and all contents and opinions are only personal. write in front A lot of things, you can’t see anything by looking at one point alone, but similar things can be seen together with patience, which is

Also doing tumor NGS testing, how are the 9 companies listed on the US stock market? Read More »

Comparison of 2022-Q2 financial reports of some tumor NGS testing companies

Original link: https://kaopubear.top/blog/2022-08-08-2022q2-ngs-precision-oncology-revenue/ 5 U.S.-listed companies are temporarily included, namely Myriad, Natera, Guardant, Veracyte and Exact Sciences. Invitae will be released on August 9. The two domestic companies listed on the U.S. stock market, Burning Rock Medicine and Genetron Health, will be released later. be added together. The stock prices of these companies on August

Comparison of 2022-Q2 financial reports of some tumor NGS testing companies Read More »

Biological characteristics, detection technology and clinical application of ctDNA

Original link: https://kaopubear.top/blog/2022-08-02-ctdna-esmo-caca-recommendation/ write in front In June 2022, the Professional Committee of Tumor Markers of the Chinese Anti-Cancer Association (CACA) published the Expert Consensus on Clinical Practice of ctDNA High-throughput Sequencing (2022 Edition) in the Chinese Journal of Cancer Prevention and Control. In July 2022, the European Society for Medical Oncology (ESMO) Precision Medicine

Biological characteristics, detection technology and clinical application of ctDNA Read More »

Learn how to learn and share within your team in Google Software Engineering

Original link: https://kaopubear.top/blog/2022-07-16-book-software-engineering-at-google/ When a friend recommended the book “Google Software Engineering” to me, I was stunned. Let’s just say that at my coding level, I would never dare to read Gou Ge’s software engineering. As a result, the other party said that they can “take a small amount of time, take it with warm

Learn how to learn and share within your team in Google Software Engineering Read More »

How to measure individual contributions to team projects

Original link: https://kaopubear.top/blog/2022-07-16-credit-a-team-member/ Being in a team (department), cooperation is an essential work method for the smooth progress of every project. But how to reasonably display and evaluate everyone’s contribution, so that everyone can see their own value, is not an easy task. I have encountered this problem several times during my work in the

How to measure individual contributions to team projects Read More »